Day: May 27, 2025

U.S. FDA Approves Starjemza, a New Stelara Biosimilar

The U.S. Food and Drug Administration (FDA) has approved Starjemza (ustekinumab-hmny) Injection, a biosimilar referencing Stelara (ustekinumab) injection